> Research summary — not medical advice. This page synthesizes published research on a mechanism-level intervention. It is not a clinical recommendation. Consult a qualified healthcare provider before making any changes to diet, supplementation, or treatment.
Intervention Summary
Increased citrus fruit consumption as a dietary source of anti-estrogenic and anti-inflammatory flavonoids — particularly naringenin (grapefruit), hesperidin (oranges, lemons), and nobiletin (citrus peel). These compounds inhibit aromatase, compete at estrogen receptors, and suppress NF-kB signaling. Gut bacteria activate citrus flavonoid glycosides into their bioactive aglycone forms.
Evidence
- Epidemiological: Higher citrus fruit intake associated with reduced endometriosis risk in large cohort studies
- In vitro: Naringenin inhibits aromatase (CYP19A1) activity in endometrial stromal cells and competes with estradiol at ERalpha and ERbeta
- Animal models: Hesperidin reduces endometriotic lesion size and vascularization in rat models; nobiletin suppresses MMP-9 expression
- Microbiome interaction: Citrus flavonoid glycosides (naringin, hesperidin) are hydrolyzed by gut bacterial beta-glucosidases (Bifidobacterium, Lactobacillus) to release bioactive aglycones
- Limitation: No RCTs specifically testing citrus fruit intervention for endometriosis outcomes
Mechanism
- Aromatase inhibition: Naringenin competitively inhibits CYP19A1 aromatase, reducing local estrogen production in ectopic endometrial tissue
- Estrogen receptor competition: Citrus flavonoids act as selective estrogen receptor modulators (SERMs), binding ERbeta with higher affinity and exerting anti-proliferative effects
- NF-kB suppression: Hesperidin and nobiletin inhibit IKK phosphorylation, reducing NF-kB-driven IL-6, IL-8, and MCP-1 expression in endometrial cells
- Microbiome-dependent activation: Bioavailability depends on gut bacterial deglycosylation — a healthy Bifidobacterium population enhances citrus flavonoid activation
Clinical Context
Citrus fruits are a low-risk dietary intervention with plausible mechanism. Two to three servings daily provide meaningful flavonoid doses. Grapefruit specifically contains naringenin but also inhibits CYP3A4 — practitioners must check for drug interactions (oral contraceptives, statins, immunosuppressants). The microbiome-dependent activation creates a positive feedback loop: restoring Bifidobacterium (via prebiotics) enhances citrus flavonoid bioavailability.
—-
> Educational content, not medical advice. This page describes mechanisms by which the intervention interacts with the microbiome and metal ecology. It is not a treatment recommendation. Clinical decisions about any intervention should be made with a qualified healthcare practitioner who knows your individual history.